Earl Randy Craven

Associate Professor

Johns Hopkins University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Earl Randy Craven is an Associate Professor at The Johns Hopkins University School of Medicine in the United States. His research primarily focuses on the management and surgical treatment of glaucoma, with recent publications examining the safety and effectiveness of various surgical interventions and implants. His work includes studies on the Bimatoprost Intracameral Implant and the XEN45 gel stent, contributing to advancements in clinical practices for patients with open-angle glaucoma and ocular hypertension.

Articles (7)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2020

Collaborators (1)

Elyse Mcglumphy

Assistant Professor of Ophthalmology

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Earl Randy Craven

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Prospective 18-Month Study of Bimatoprost Intracameral Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension in US Clinical Practice

Effectiveness and safety of the XEN45 gel stent compared to trabeculectomy in primary open-angle glaucoma: the Gold-Standard Pathway Study

Update on Surgical Techniques Best Practices to Optimize Outcomes Following Gel Stent Implantation

Interim Analysis of Clinical Outcomes with Open versus Closed Conjunctival Implantation of the XEN45 Gel Stent

Real-World Study of the Effectiveness and Safety of Intracameral Bimatoprost Implant in a Clinical Setting in the United States

Phase 3, Randomized Study Comparing Intracameral Bimatoprost Implant 15 μg and Selective Laser Trabeculectomy in Patients with Open-Angle Glaucoma or Ocular Hypertension

24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients

Collaborators (1)

Elyse Mcglumphy

Make your next move.